Company intelligence / Profile preview

Braincare

Colorado, United Statesbraincareshop.com ↗

Ownership: Private
Development stage: Commercial

Overview

Braincare offers non-invasive, drug-free cognitive enhancement using MeRT technology. Clinical studies referenced include safety and efficacy evaluations for substance use disorders, PTSD, autism spectrum disorder, major depressive disorder, and brain injury. The company uses FDA-cleared TMS equipment tailored by individual EEG mapping to optimize outcomes. Published research supports improvements in clinical phenotype and brain activity metrics for several neuropsychiatric conditions.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceNon-pharmacological therapyTranscranial Magnetic Stimulation (TMS)–based therapy
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Braincare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Braincare.

Explore the full profile